Literature DB >> 16177543

Preferable anesthetic conditions for echocardiographic determination of murine cardiac function.

Yuji Kawahara1, Kouichi Tanonaka, Takuya Daicho, Mikio Nawa, Ryo Oikawa, Yoshihisa Nasa, Satoshi Takeo.   

Abstract

Ketamine and xylazine are routinely used for measurement of hemodynamics of mice and rats by echocardiography. The anesthetic agents produce low heart rate (HR) in the animals, which may result in misleading data in the hemodynamic profiles of the small animals. The purpose of the present study was to select an appropriate anesthetic condition in the evaluation of mouse and rat cardiac function by echocardiography. Echocardiographic measurement was performed in male C57BL6 mice anesthetized with an intraperitoneal injection of 30 or 40 mg/kg pentobarbital (P30 or P40) or a combination of 60 mg/kg ketamine and 6 mg/kg xylazine (KX) and in male Wistar rats with an intraperitoneal injection of 40 or 50 mg/kg pentobarbital (P40 or P50) or a combination of 100 mg/kg ketamine and 10 mg/kg xylazine (KX). Basal HR of P30-anesthetized mice and P40-anesthetized were comparable to those in the conscious state, whereas KX-anesthetized mice and rats were 38% and 74% of those of the conscious animals, respectively. Fractional shortening (FS) and cardiac output index (COI) of the P30-anesthetized mice or the P40-anesthetized rats were greater than those of KX-anesthetized animals. Intraperitoneal injection of dobutamine at 0.3 and 1 mg/kg increased HR, FS, and COI of the P30-anesthetized mice and the P40-anesthetized rats, respectively, whereas the percent responses of these parameters in KX animals were greater than those in pentobarbital-anesthetized ones due to the lower basal values for the cardiac functional parameters. Anesthesia with P30 for the mouse and P40 for the rat rather than ketamine/xylazine may be relevant to the evaluation of cardiac function using echocardiography.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16177543     DOI: 10.1254/jphs.fp0050343

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  26 in total

1.  Echocardiographic and electrocardiographic characteristics of male and female squirrel monkeys (Saimiri spp.).

Authors:  Monika K Huss; Fumiaki Ikeno; Christine L Buckmaster; Megan A Albertelli
Journal:  J Am Assoc Lab Anim Sci       Date:  2015-01       Impact factor: 1.232

2.  Best anesthetics for assessing left ventricular systolic function by echocardiography in mice.

Authors:  Ronald E Pachon; Bruce A Scharf; Dorothy E Vatner; Stephen F Vatner
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-04-10       Impact factor: 4.733

Review 3.  New approaches in small animal echocardiography: imaging the sounds of silence.

Authors:  Rashmi Ram; Deanne M Mickelsen; Catherine Theodoropoulos; Burns C Blaxall
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-08-26       Impact factor: 4.733

4.  Cardiac mechanoenergetic cost of elevated plasma viscosity after moderate hemodilution.

Authors:  Surapong Chatpun; Pedro Cabrales
Journal:  Biorheology       Date:  2010       Impact factor: 1.875

5.  Neprilysin null mice develop exaggerated pulmonary vascular remodeling in response to chronic hypoxia.

Authors:  Edward C Dempsey; Marilee J Wick; Vijaya Karoor; Erica J Barr; Dustin W Tallman; Carol A Wehling; Sandra J Walchak; Sven Laudi; Mysan Le; Masahiko Oka; Susan Majka; Carlyne D Cool; Karen A Fagan; Dwight J Klemm; Louis B Hersh; Norma P Gerard; Craig Gerard; York E Miller
Journal:  Am J Pathol       Date:  2009-03       Impact factor: 4.307

6.  Safety and efficacy of various combinations of injectable anesthetics in BALB/c mice.

Authors:  Sandra Buitrago; Thomas E Martin; Joanne Tetens-Woodring; Alan Belicha-Villanueva; Gregory E Wilding
Journal:  J Am Assoc Lab Anim Sci       Date:  2008-01       Impact factor: 1.232

7.  Murine pulmonary response to chronic hypoxia is strain specific.

Authors:  Yuji Tada; Sven Laudi; Julie Harral; Michelle Carr; Charles Ivester; Nobuhiro Tanabe; Yuichi Takiguchi; Koichiro Tatsumi; Takayuki Kuriyama; William C Nichols; James West
Journal:  Exp Lung Res       Date:  2008-08       Impact factor: 2.459

8.  Improving cardiac function with new-generation plasma volume expanders.

Authors:  Surapong Chatpun; Parimala Nacharaju; Pedro Cabrales
Journal:  Am J Emerg Med       Date:  2012-08-03       Impact factor: 2.469

9.  Anesthetic Activity of Alfaxalone Compared with Ketamine in Mice.

Authors:  Parkpoom Siriarchavatana; Jessica D Ayers; Lon V Kendall
Journal:  J Am Assoc Lab Anim Sci       Date:  2016       Impact factor: 1.232

10.  Protective effect of geranylgeranylacetone via enhancement of HSPB8 induction in desmin-related cardiomyopathy.

Authors:  Atsushi Sanbe; Takuya Daicho; Reiko Mizutani; Toshiya Endo; Noriko Miyauchi; Junji Yamauchi; Kouichi Tanonaka; Charles Glabe; Akito Tanoue
Journal:  PLoS One       Date:  2009-04-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.